Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Lo Nigro

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Ebiomedicine|August 19, 2022
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120Grazia Fazio, Silvia Bresolin, Daniela Silvestri, et al.
Annals of Hematology|April 12, 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life studySalvatore Leotta, Uros Markovic, Andrea Duminuco, et al.
Blood|February 19, 2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000Anja Möricke, Martin Zimmermann, Maria Grazia Valsecchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter, et al.
Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.
Blood|May 10, 2011
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyEva A Coenen, Susana C Raimondi, Jochen Harbott, et al.
Blood|June 17, 2009
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective studyBrian V Balgobind, Susana C Raimondi, Jochen Harbott, et al.
Haematologica|April 29, 2022
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangementSimon Bomken, Amir Enshaei, Edward C Schwalbe, et al.
Blood|June 25, 2024
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Ruth Shiloh, Jan L C Loeffen, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Ebiomedicine|August 19, 2022
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120Grazia Fazio, Silvia Bresolin, Daniela Silvestri, et al.
Annals of Hematology|April 12, 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life studySalvatore Leotta, Uros Markovic, Andrea Duminuco, et al.
Blood|February 19, 2016
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000Anja Möricke, Martin Zimmermann, Maria Grazia Valsecchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1Annelisa M Cornel, Loutje van der Sman, Jip T van Dinter, et al.
Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.
Blood|May 10, 2011
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyEva A Coenen, Susana C Raimondi, Jochen Harbott, et al.
Blood|June 17, 2009
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective studyBrian V Balgobind, Susana C Raimondi, Jochen Harbott, et al.
Haematologica|April 29, 2022
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangementSimon Bomken, Amir Enshaei, Edward C Schwalbe, et al.
Blood|June 25, 2024
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Ruth Shiloh, Jan L C Loeffen, et al.
Pageof 7